Imaging In-Depth Focus 2020
Posted: 26 May 2020 | Drug Target Review | No comments yet
The articles in this in-depth focus discuss the difficulties in deciding what information to capture when imaging three-dimensional (3D) cell models and the use of non-invasive imaging techniques to discover small molecule drugs to control protein translation.
In this in-depth focus:
- Data, data and still more data: the challenges of imaging and analysing 3D cell models
The latest generation of three-dimensional (3D) cell models offer new and exciting possibilities for pharmaceutical research. However, deciding how to capture sufficient information in the most efficient way from an experiment without making the data size overwhelming can prove challenging. Margaritha Mysior and Jeremy Simpson discuss the opportunities and challenges faced by researchers currently working in this field. - Seeing the light – visualising protein translation in real time
Non-invasive imaging has played an increasing role in drug discovery and development processes. Nikki Withers spoke with Yochi Slonim, who discusses a novel technology that leverages FRET signals for the discovery of small molecule drugs that selectively control mRNA translation in a novel target space.
Related topics
Analytical techniques, Disease research, Drug Discovery, Drug Discovery Processes, Drug Targets, Genomics, Imaging, Organoids, Protein, Protein Expression, Proteomics, RNAs, Therapeutics
Related organisations
Molecular Devices